Farnesoid X Receptor an Emerging Target to Combat Obesity

Publisher： Karger

E-ISSN： 1421-9875|35|3|185-190

ISSN： 0257-2753

Source： Digestive Diseases, Vol.35, Iss.3, 2017-03, pp. : 185-190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Progesterone Metabolites as Farnesoid X Receptor Inhibitors

By  

Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. : 300-306

Karger

Access to resources Recommend Favorite

The Farnesoid X Receptor (FXR) as Modulator of Bile Acid Metabolism

By Kuipers Folkert   Claudel Thierry   Sturm Ekkehard   Staels Bart  

Reviews in Endocrine and Metabolic Disorders, Vol. 5, Iss. 4, 2004-12 ,pp. : 319-326

Springer Publishing Company

Access to resources Recommend Favorite

Use of Farnesoid X Receptor Agonists to Treat Nonalcoholic Fatty Liver Disease

By  

Digestive Diseases, Vol. 33, Iss. 3, 2015-05 ,pp. : 426-432

Karger

Access to resources Recommend Favorite

Intestinal Farnesoid X Receptor Signaling Modulates Metabolic Disease

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 178-184

Karger

Access to resources Recommend Favorite

Intestinal Farnesoid X Receptor and Takeda G Protein Couple Receptor 5 Signaling in Metabolic Regulation

By  

Digestive Diseases, Vol. 35, Iss. 3, 2017-03 ,pp. : 241-245

Karger

Access to resources Recommend Favorite